Double-blind trial, 293 postmenopausal women having prolapse surgery: at 12 months 92% on vaginal oestriol cream vs 80% on placebo reported symptom improvement (p=0.02). Anatomical outcomes, sexual function and reintervention did not differ; 57 dropped out.
RCTn = 293
Vodegel et al. Vaginal Oestrogen Therapy for Postmenopausal Women Undergoing Prolapse Surgery: A Multicentre Double-Blind Randomised Placebo-Controlled Clinical Trial